• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性转甲状腺素蛋白淀粉样变性引起的严重慢性腹泻。

Severe chronic diarrhoea caused by hereditary transthyretin amyloidosis.

机构信息

Gastroenterology Unit, Department of Biomedical and Clinical Sciences, University of Milan, Milano, Italy

Gastroenterology Unit, Department of Biomedical and Clinical Sciences, University of Milan, Milano, Italy.

出版信息

BMJ Case Rep. 2023 Oct 16;16(10):e256673. doi: 10.1136/bcr-2023-256673.

DOI:10.1136/bcr-2023-256673
PMID:37844979
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10583022/
Abstract

Amyloidosis includes a heterogeneous group of diseases caused by the extracellular deposition of insoluble fibrillar proteins, leading to multiple organ dysfunction and a poor life expectancy. In the early stages of amyloidosis, gastrointestinal (GI) symptoms are uncommon. We describe a rare case of hereditary transthyretin amyloidosis (ATTRv) with involvement of the heart, nervous system and GI tract. A man in his 60s was hospitalised due to chronic diarrhoea, orthostatic hypotension, malabsorption and weight loss. An organic origin for the diarrhoea was suspected, but the most common causes were ruled out. The review of GI biopsies and an abdominal fat aspirate confirmed the diagnosis of amyloidosis. The diagnosis of ATTRv amyloidosis with GI presentation is challenging, especially in the early stages, and misdiagnosis is common. The recent approval of therapies emphasises the importance of early diagnosis to prevent irreversible organ damage.

摘要

淀粉样变性症包括一组由不溶性纤维状蛋白质细胞外沉积引起的异质性疾病,导致多器官功能障碍和预期寿命缩短。在淀粉样变性症的早期阶段,胃肠道(GI)症状并不常见。我们描述了一例罕见的遗传性转甲状腺素蛋白淀粉样变性症(ATTRv),涉及心脏、神经系统和胃肠道。一名 60 多岁的男子因慢性腹泻、直立性低血压、吸收不良和体重减轻而住院。腹泻的器质性病因被怀疑,但最常见的病因已被排除。对胃肠道活检和腹部脂肪抽吸的检查结果证实了淀粉样变性症的诊断。以胃肠道表现为特征的 ATTRv 淀粉样变性症的诊断具有挑战性,尤其是在早期阶段,误诊很常见。最近批准的治疗方法强调了早期诊断的重要性,以防止不可逆转的器官损伤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e60/10583022/e7e80c02a75c/bcr-2023-256673f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e60/10583022/d4ea77167315/bcr-2023-256673f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e60/10583022/1b0969f3d9a5/bcr-2023-256673f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e60/10583022/e7e80c02a75c/bcr-2023-256673f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e60/10583022/d4ea77167315/bcr-2023-256673f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e60/10583022/1b0969f3d9a5/bcr-2023-256673f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e60/10583022/e7e80c02a75c/bcr-2023-256673f03.jpg

相似文献

1
Severe chronic diarrhoea caused by hereditary transthyretin amyloidosis.遗传性转甲状腺素蛋白淀粉样变性引起的严重慢性腹泻。
BMJ Case Rep. 2023 Oct 16;16(10):e256673. doi: 10.1136/bcr-2023-256673.
2
Management of gastrointestinal complications in hereditary transthyretin amyloidosis: a single-center experience over 40 years.遗传性转甲状腺素蛋白淀粉样变性症胃肠道并发症的管理:40 多年单中心经验。
Expert Rev Gastroenterol Hepatol. 2018 Jan;12(1):73-81. doi: 10.1080/17474124.2018.1397511. Epub 2017 Nov 20.
3
Recommendations for the diagnosis and management of transthyretin amyloidosis with gastrointestinal manifestations.转甲状腺素蛋白淀粉样变性伴胃肠道表现的诊断与管理建议。
Eur J Gastroenterol Hepatol. 2021 May 1;33(5):613-622. doi: 10.1097/MEG.0000000000002030.
4
Hereditary transthyretin amyloidosis: a case report.遗传性转甲状腺素蛋白淀粉样变性:一例报告。
J Med Case Rep. 2022 Jun 25;16(1):248. doi: 10.1186/s13256-022-03437-0.
5
First Norwegian case of hereditary ATTR amyloidosis with a novel transthyretin variant.首例挪威遗传性ATTR 淀粉样变伴新型转甲状腺素蛋白变异。
Scand Cardiovasc J. 2023 Dec;57(1):2174269. doi: 10.1080/14017431.2023.2174269.
6
Evaluation and Management Strategies for GI Involvement with Amyloidosis.评估和管理策略为胃肠道参与淀粉样变性。
Am J Med. 2022 Apr;135 Suppl 1:S20-S23. doi: 10.1016/j.amjmed.2022.01.008. Epub 2022 Jan 22.
7
Novel approaches to diagnosis and management of hereditary transthyretin amyloidosis.遗传性转甲状腺素蛋白淀粉样变性病诊断与管理的新方法。
J Neurol Neurosurg Psychiatry. 2022 Jun;93(6):668-678. doi: 10.1136/jnnp-2021-327909. Epub 2022 Mar 7.
8
Diagnosis and treatment of gastrointestinal dysfunction in hereditary TTR amyloidosis.遗传性转甲状腺素淀粉样变性病的胃肠功能障碍的诊断与治疗。
Clin Auton Res. 2019 Sep;29(Suppl 1):55-63. doi: 10.1007/s10286-019-00628-6. Epub 2019 Aug 26.
9
Screening for ATTR amyloidosis in the clinic: overlapping disorders, misdiagnosis, and multiorgan awareness.临床中 ATTR 淀粉样变的筛查:重叠性疾病、误诊和多器官意识。
Heart Fail Rev. 2022 May;27(3):785-793. doi: 10.1007/s10741-021-10080-2. Epub 2021 Feb 20.
10
Early diagnosis in ATTRv amyloidosis, how early is enough? How early is possible?ATTRv 淀粉样变中的早期诊断,多早才算足够?多早才有可能?
Med Clin (Barc). 2024 Jun 28;162(12):e70-e73. doi: 10.1016/j.medcli.2024.02.013. Epub 2024 Apr 12.

引用本文的文献

1
Atypical Presentation of Hereditary ATTR Amyloidosis with Gastrointestinal and Hepatic Manifestations in an 88-Year-Old Woman: A Case Report.88岁女性遗传性转甲状腺素蛋白淀粉样变的非典型表现伴胃肠道和肝脏表现:病例报告
Am J Case Rep. 2025 Aug 17;26:e947690. doi: 10.12659/AJCR.947690.

本文引用的文献

1
Amyloid nomenclature 2022: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee.淀粉样变命名 2022:更新、新型蛋白质以及国际淀粉样变性学会(ISA)命名委员会的建议。
Amyloid. 2022 Dec;29(4):213-219. doi: 10.1080/13506129.2022.2147636. Epub 2022 Nov 24.
2
Hereditary transthyretin amyloidosis: a case report.遗传性转甲状腺素蛋白淀粉样变性:一例报告。
J Med Case Rep. 2022 Jun 25;16(1):248. doi: 10.1186/s13256-022-03437-0.
3
Endoscopic diagnosis of chronic diarrhea.慢性腹泻的内镜诊断
DEN Open. 2021 Sep 28;2(1):e53. doi: 10.1002/deo2.53. eCollection 2022 Apr.
4
Intestinal amyloidosis: Clinical manifestations and diagnostic challenge.肠道淀粉样变性:临床表现和诊断挑战。
Adv Clin Exp Med. 2021 May;30(5):563-570. doi: 10.17219/acem/133521.
5
Diagnosing Transthyretin Cardiac Amyloidosis by Technetium Tc 99m Pyrophosphate: A Test in Evolution.锝 99m 焦磷酸盐诊断转甲状腺素心脏淀粉样变性:一项不断发展的试验。
JACC Cardiovasc Imaging. 2021 Jun;14(6):1221-1231. doi: 10.1016/j.jcmg.2020.08.027. Epub 2020 Nov 18.
6
Hereditary transthyretin amyloidosis overview.遗传性转甲状腺素蛋白淀粉样变性概述。
Neurol Sci. 2022 Dec;43(Suppl 2):595-604. doi: 10.1007/s10072-020-04889-2. Epub 2020 Nov 14.
7
Systemic amyloidosis from A (AA) to T (ATTR): a review.系统性淀粉样变,从 A(AA)到 T(ATTR):综述。
J Intern Med. 2021 Mar;289(3):268-292. doi: 10.1111/joim.13169. Epub 2020 Sep 14.
8
Transthyretin Amyloidosis with Gastrointestinal Manifestation: a Case Report.转甲状腺素蛋白淀粉样变性伴胃肠道表现:一例报告。
J Gastrointestin Liver Dis. 2019 Sep 1;28(3):359-361. doi: 10.15403/JGLD-422.
9
Patisiran, an RNAi therapeutic for the treatment of hereditary transthyretin-mediated amyloidosis.帕替拉韦,一种用于治疗遗传性转甲状腺素蛋白介导的淀粉样变性的RNA干扰疗法。
Neurodegener Dis Manag. 2019 Feb;9(1):5-23. doi: 10.2217/nmt-2018-0033. Epub 2018 Nov 27.
10
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.特发性甲状腺素运载蛋白淀粉样变心肌病患者的塔法米迪治疗。
N Engl J Med. 2018 Sep 13;379(11):1007-1016. doi: 10.1056/NEJMoa1805689. Epub 2018 Aug 27.